Apollomics (Australia) Pty. Ltd.
2 clinical trials · Sponsor
◉ Watch Apollomics (Australia) Pty. Ltd.
| Record | Firm | Date |
|---|---|---|
| APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC (NCT03655613) | Apollomics (Australia) Pty. Ltd. | 2018-09-05 |
Track Apollomics (Australia) Pty. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.